Pharmacologic management of bladder dysfunction in adult women

J Obstet Gynecol Neonatal Nurs. 2014 Mar-Apr;43(2):253-63. doi: 10.1111/1552-6909.12287. Epub 2014 Feb 6.

Abstract

Women commonly experience lower urinary tract symptoms that can severely decrease quality of life. Symptoms are often associated with diagnoses such as urinary incontinence, overactive bladder, and bladder pain syndrome. Expanding evidence supports the effectiveness of many basic nursing interventions, including behavioral management education and optimal use of various pharmacologic agents. The primary focus of this article is pharmacologic treatment of urinary symptoms in women, including new and emerging agents.

Keywords: Urinary incontinence; bladder pain syndrome; overactive bladder; pharmacologic management.

Publication types

  • Review

MeSH terms

  • Acetanilides / therapeutic use
  • Administration, Cutaneous
  • Administration, Oral
  • Adult
  • Aged
  • Botulinum Toxins / therapeutic use*
  • Cystitis, Interstitial / diagnosis
  • Cystitis, Interstitial / drug therapy
  • Estrogens / therapeutic use
  • Female
  • Humans
  • Mandelic Acids / therapeutic use
  • Middle Aged
  • Prognosis
  • Risk Assessment
  • Severity of Illness Index
  • Thiazoles / therapeutic use
  • Treatment Outcome
  • Urinary Bladder Diseases / diagnosis
  • Urinary Bladder Diseases / drug therapy*
  • Urinary Bladder, Overactive / diagnosis
  • Urinary Bladder, Overactive / drug therapy
  • Urinary Incontinence / diagnosis
  • Urinary Incontinence / drug therapy
  • Urinary Incontinence, Stress / diagnosis
  • Urinary Incontinence, Stress / drug therapy
  • Urination Disorders / diagnosis
  • Urination Disorders / drug therapy*
  • Urodynamics
  • Urological Agents / therapeutic use*

Substances

  • Acetanilides
  • Estrogens
  • Mandelic Acids
  • Thiazoles
  • Urological Agents
  • Botulinum Toxins
  • oxybutynin
  • mirabegron